Will Anthem’s New Pathway Program for Oncologist Succeed in Lowering Costs?

Anthem recently unveiled a new framework for treatment through its Cancer Care Quality Program in an effort to combat high pharmaceutical prices and ease the tense relationship between oncologist and insurers. Learn more here. (Source: Journal of Clinical Pathways, 9/8/15)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… July 22, 2019
Biomarkers and Companion diagnostics: Payer Insights September 26, 2019
Leveraging Technology to Reduce Costs in Clinical Trials June 30, 2019
Pharmerit Expands Market Access Support in Asia January 17, 2019
FDA Has Big Changes Planned for Medical Device Approval Pipeline November 26, 2018
The Global Use of Medicine in 2019 and Outlook to 2023 January 29, 2019
The Future of Key Account Management in Pharma September 26, 2019